Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

SELL
$12.43 - $15.29 $331,060 - $407,233
-26,634 Reduced 3.65%
704,055 $8.99 Million
Q2 2023

Aug 10, 2023

BUY
$12.92 - $15.89 $10,206 - $12,553
790 Added 0.11%
730,689 $10 Million
Q1 2023

May 11, 2023

BUY
$13.67 - $16.37 $223,285 - $267,387
16,334 Added 2.29%
729,899 $11.2 Million
Q4 2022

Feb 08, 2023

SELL
$12.05 - $15.14 $671,136 - $843,237
-55,696 Reduced 7.24%
713,565 $9.57 Million
Q3 2022

Nov 10, 2022

SELL
$12.82 - $20.22 $472,006 - $744,459
-36,818 Reduced 4.57%
769,261 $10.2 Million
Q2 2022

Aug 12, 2022

BUY
$17.89 - $20.47 $508,773 - $582,146
28,439 Added 3.66%
806,079 $15.4 Million
Q1 2022

May 12, 2022

BUY
$18.39 - $21.85 $24,017 - $28,536
1,306 Added 0.17%
777,640 $15.5 Million
Q4 2021

Feb 09, 2022

BUY
$18.96 - $22.76 $246,916 - $296,403
13,023 Added 1.71%
776,334 $15.9 Million
Q3 2021

Nov 09, 2021

BUY
$20.59 - $30.01 $1.79 Million - $2.62 Million
87,138 Added 12.89%
763,311 $16.4 Million
Q2 2021

Aug 11, 2021

BUY
$24.15 - $30.08 $1.45 Million - $1.81 Million
60,242 Added 9.78%
676,173 $19.5 Million
Q1 2021

May 12, 2021

BUY
$19.71 - $25.23 $3.51 Million - $4.49 Million
178,068 Added 40.67%
615,931 $15 Million
Q4 2020

Feb 11, 2021

BUY
$16.44 - $20.2 $1.1 Million - $1.36 Million
67,114 Added 18.1%
437,863 $8.5 Million
Q3 2020

Nov 12, 2020

BUY
$17.36 - $26.36 $623,588 - $946,877
35,921 Added 10.73%
370,749 $6.45 Million
Q1 2020

May 13, 2020

BUY
$17.75 - $27.72 $1.84 Million - $2.87 Million
103,623 Added 44.82%
334,828 $8.09 Million
Q4 2019

Feb 11, 2020

BUY
$21.0 - $24.83 $2.62 Million - $3.1 Million
124,744 Added 117.17%
231,205 $5.74 Million
Q3 2019

Nov 12, 2019

BUY
$20.34 - $32.66 $2.17 Million - $3.48 Million
106,461 New
106,461 $2.27 Million

Others Institutions Holding PAHC

About PHIBRO ANIMAL HEALTH CORP


  • Ticker PAHC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 20,337,600
  • Market Cap $440M
  • Description
  • Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy c...
More about PAHC
Track This Portfolio

Track Heartland Advisors Inc Portfolio

Follow Heartland Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heartland Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Heartland Advisors Inc with notifications on news.